CVE-2026-33939
Multiple vulnerabilities have been discovered in IBM products. Some of them allow an attacker to cause remote arbitrary code execution, privilege escalation, and remote denial of service.
CSIRTS triage
- What
- Multiple vulnerabilities in IBM products allow remote arbitrary code execution, privilege escalation, and remote denial of service.
- Who is affected
- Multiple IBM product deployments are affected across unspecified versions.
- Urgency
- High; exploitation is actively occurring and includes remote code execution.
- Action
- Identify affected IBM products from the CVE list and apply vendor patches for CVE-2026-5588, CVE-2026-33871, and related CVEs.
AI-assisted analysis generated from the source advisory — verify against the original.
⚡ Watch CVE-2026-33939
Get an email if CVE-2026-33939 is added to CISA KEV, gains public exploit code, or a new advisory cites it — max one per day, one-click unsubscribe.
Exploitation outlook
- Low exploitation risk0.62% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 47% of all EPSS-scored CVEs.
Advisory coverage (1)
- unknownexploitedMultiple vulnerabilities in IBM products (August 14, 2026)cert-fr-avis · 2026-08-14
External references
Embed the live status
— this badge updates automatically when the KEV or exploit status changes. How to embed it →
[](https://www.csirts.com/cve/CVE-2026-33939)